Brief: Humacyte Q4 Basic EPS USD -0.13
27/03/2026 11:00
Mar 27 (Reuters) - Humacyte Q4 operating income USD -30.836 million vs. IBES estimate USD -22.8 million. Q4 net income USD -24.804 million vs. IBES estimate USD -23.3 million Q4 operating expenses USD 31.303 million
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary